Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

3256.22 (Glytoucan)

Id:0b340e0a-274e-5fd7-b641-ec16e7092a13

Glytoucan:G01291IM

Results found

Linked to

	Label	Description
	3256.22 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000001 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3256.22 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000026 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3256.22 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000013 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3256.22 has canonical residue n-glycan core b-d-glcpnac b Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3256.22 has glycosequence GLYGEN.GLYCOSEQUENCE:G71850TH-GLYCOSEQ00085112 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3256.22 has glycosequence GLYGEN.GLYCOSEQUENCE:G53303ZX-GLYCOSEQ00077365 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3256.22 has glycosequence GLYGEN.GLYCOSEQUENCE:G01291IM-GLYCOSEQ00191390 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3256.22 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000014 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3256.22 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3256.22 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000020 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3256.22 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000001 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3256.22 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000026 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3256.22 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000013 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3256.22 has canonical residue n-glycan core b-d-glcpnac b

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3256.22 has glycosequence GLYGEN.GLYCOSEQUENCE:G71850TH-GLYCOSEQ00085112 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3256.22 has glycosequence GLYGEN.GLYCOSEQUENCE:G53303ZX-GLYCOSEQ00077365 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3256.22 has glycosequence GLYGEN.GLYCOSEQUENCE:G01291IM-GLYCOSEQ00191390 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3256.22 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000014 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3256.22 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000019 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3256.22 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000020 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.